Keros Therapeutics, Inc. (KROS)

SEC filing

Keros Therapeutics, Inc.

KROS · CIK 1664710

4 · Aug 20, 2026 · Director Newton Charles W. sold 551 shares at $10.30/share ($5,675)

Director Newton Charles W. sold 551 shares at $10.30/share ($5,675)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.